Old Web
English
Sign In
Acemap
>
authorDetail
>
Peter Probst
Peter Probst
GlaxoSmithKline
Biology
Immunology
Lipopolysaccharide
Biochemistry
Receptor
4
Papers
430
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis
2009
Fems Immunology and Medical Microbiology
Rhea N. Coler
Ajay Bhatia
Jean-François Maisonneuve
Peter Probst
Brenda Barth
Pamela J. Ovendale
Hang Fang
Mark R. Alderson
Yves Lobet
Joe Cohen
Pascal Mettens
Steven G. Reed
Show All
Source
Cite
Save
Citations (39)
TLR4 agonists as immunomodulatory agents
2006
Journal of Endotoxin Research
Mark R. Alderson
Patrick Mcgowan
Jory R. Baldridge
Peter Probst
Show All
Source
Cite
Save
Citations (71)
A Synthetic TLR4 Antagonist Has Anti-Inflammatory Effects in Two Murine Models of Inflammatory Bowel Disease
2005
Journal of Immunology
Madeleine M. Fort
Afsaneh Mozaffarian
Axel G. Stöver
Jean da Silva Correia
David A. Johnson
R. Thomas Crane
Richard J. Ulevitch
David H. Persing
Helle Bielefeldt-Ohmann
Peter Probst
Eric W. Jeffery
Steven P. Fling
Robert M. Hershberg
Show All
Source
Cite
Save
Citations (191)
Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists
2004
Journal of Biological Chemistry
Axel G. Stöver
Jean da Silva Correia
Jay T. Evans
Christopher W. Cluff
Mark W. Elliott
Eric W. Jeffery
David A. Johnson
Michael J. Lacy
Jory R. Baldridge
Peter Probst
Richard J. Ulevitch
David H. Persing
Robert M. Hershberg
Show All
Source
Cite
Save
Citations (129)
1